Effect of maternal body mass index on in vitro response to tocolytics in term myometrium

Am J Obstet Gynecol. 2010 Sep;203(3):261.e1-5. doi: 10.1016/j.ajog.2010.05.029. Epub 2010 Jul 14.

Abstract

Objective: We sought to investigate the effect of body mass index (BMI) on in vitro response to tocolytics.

Study design: Myometrial biopsies were obtained at the time of scheduled cesarean deliveries from term nonlaboring women with BMI < or =29.9 (26.3 +/- 1.3; n = 7), 30-34.9 (31.8 +/- 1.2; n = 16), and > or = 35 (39.5 +/- 4.9; n = 9). Tissue strips were suspended in organ chambers for isometric tension recording. The effects of cumulative doses (10(-10) to 10(-5) mol/L) of nifedipine or indomethacin on spontaneous uterine contractility were determined. Areas under the contraction curve were compared using 1-way analysis of variance with Tukey post hoc test.

Results: Myometrial response to tocolytics did not differ between the BMI groups. Nifedipine, but not indomethacin, significantly inhibited myometrial contractility independent of BMI.

Conclusion: BMI does not affect uterine response to tocolytics in isolated uterine tissue from term nonlaboring women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Area Under Curve
  • Biopsy
  • Body Mass Index*
  • Female
  • Humans
  • In Vitro Techniques
  • Indomethacin / pharmacology*
  • Myometrium / drug effects
  • Myometrium / pathology
  • Nifedipine / pharmacology*
  • Pregnancy
  • Tocolytic Agents / pharmacology*
  • Uterine Contraction / drug effects*

Substances

  • Tocolytic Agents
  • Nifedipine
  • Indomethacin